Diagnosis and management of COVID-19 disease

American Journal of Respiratory and Critical Care Medicine

Volumn 201, Issue 10, 2020, Pages P19-P22

  Jamil, Shazia ^a   Mark, Nick ^b   Carlos, Graham ^c   Dela Cruz, Charles S ^d   Gross, Jane E ^e   Pasnick, Susan ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Indiana University   (United States)

^d YALE UNIVERSITY   (United States)

^e DEPARTMENT OF MEDICINE   (United States)

^f Medical Oncology   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT;

ARTICLE; BLOOD CELL COUNT; CASE FATALITY RATE; CORONAVIRUS DISEASE 2019; DIAGNOSTIC TEST; DISEASE SEVERITY; EXPERIMENTAL THERAPY; HUMAN; IN VITRO STUDY; INFECTION CONTROL; LABORATORY TEST; POINT OF CARE ULTRASOUND; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; PROGNOSIS; RESPIRATORY FAILURE; THORAX RADIOGRAPHY; WORLD HEALTH ORGANIZATION; X-RAY COMPUTED TOMOGRAPHY; BETACORONAVIRUS; CORONAVIRUS INFECTION; PANDEMIC; VIRUS PNEUMONIA;

BETACORONAVIRUS; CORONAVIRUS INFECTIONS; HUMANS; PANDEMICS; PNEUMONIA, VIRAL;

EID: 85083249835     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.2020C1     Document Type: Article

References (26)

1. Peng Z, et al. “A pneumonia outbreak associated with a new coronavirus of probable bat origin.” Nature: 579, 270-273(2020).
2. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc. gov%2Fcoronavirus%2F2019-ncov%2Fprepare%2Ftransmission.html (accessed 3/20/2020).
3. Xiao F, et al. “Evidence for gastrointestingal infection of SARSCoV-2.” Gastroenterology (2020), doi: https://doi.org/10.1053/j.gastro.2020.02.055.
4. Wu D, et al. “The SARS-CoV-2 outbreak: what we know.” International Journal of Infectious Diseases (2020), doi: https://doi.org/10.1016/j.ijid.2020.03.004.
5. http://www.nephjc.com/news/covidace2 (accessed 3/21/2020).
6. Lauer S, et al. “The Incubation Period of Coronavirus Disease 2019 (COVID-19) from Publicly Reported Confirmed Cases: Estimation and Application.” Annals of Internal Medicine: 10 March 2020.
7. Zhou F, et al. “Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a restrospective cohort study. Lancet. 2020 Mar 11. pii: S0140-6736(20)30566-3. doi: 10.1016/ S0140-6736(20)30566-3.
8. Xiaolu Tang, Changcheng Wu, Xiang Li, Yuhe Song, Xinmin Yao, Xinkai Wu, Yuange Duan, Hong Zhang, Yirong Wang, Zhaohui Qian, Jie Cui, Jian Lu, On the origin and continuing evolution of SARS-CoV-2, National Science Review, nwaa036, https://doi.org/10.1093/nsr/nwaa036
9. https://www.who.int/docs/default-source/coronaviruse/situationreports/20200306-sitrep-46-covid-19.pdf?sfvrsn=96b04adf_2 (accessed 5/20/2020).
10. Guan W, et al. “Clinical Characteristics of Coronavirus Disease 2019 in China.” NEJM. DOI: 10.1056/NEJMoa2002032.
11. https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinicalspecimens.html (accessed 5/20/2020)
12. https://aabronchology.org/2020/03/12/2020-aabip-statement-onbronchoscopy-covid-19-infection/ (accessed 3/21/2020)
13. https://aabronchology.org/2020/03/12/2020-aabip-statement-onbronchoscopy-covid-19-infection/ (accessed 3/23/2020)
14. https://www.cdc.gov/coronavirus/2019-ncov/infection-control/controlrecommendations.html (accessed 5/20/2020)
15. Board on Health Sciences Policy; Institute of Medicine. The Use and Effectiveness of Powered Air Purifying Respirators in Health Care: Workshop Summary. Washington (DC): National Academies Press (US); 2015 May 7. 2, Defining PAPRs and Current Standards. Available from: https://www.ncbi.nlm.nih.gov/books/NBK294223/
16. https://www.hematology.org/covid-19/covid-19-and-vteanticoagulation (accessed 5/20/20)
17. Ziehr DR et al. Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study. Am J Respir Crit Care Med. 2020 Apr 29. doi: 10.1164/rccm.202004-1163LE. [Epub ahead of print]
18. Alhazzani, W., Møller, M.H., Arabi, Y.M. et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 46, 854–887 (2020). https://doi.org/10.1007/s00134-020-06022-5
19. Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Hematology 2020, Published online May 11, doi: 10.1016/S2352-3026(20)30145-9
20. Henry B. “COVID-19, ECMO, and lymphopenia: a word of caution.” Lancet: DOI:https://doi.org/10.1016/S2213-2600(20)30119-3.
21. Arentz M, Yim E, Klaff L, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. Published online March 19, 2020. doi:10.1001/jama.2020.4326
22. Chao, T. et al. Guidelines from the COVID-19 Tracheotomy Task Force, a Working Group of the Airway Safety Committee of the University of Pennsylvania Health System Tracheotomy in Ventilated Patients With COVID-19, Annals of Surgery: May 19, 2020 - Volume Publish Ahead of Print - Issue - doi: 10.1097/SLA.0000000000003956
23. https://www.covid19treatmentguidelines.nih.gov (accessed 5/20/20)
24. Mercuro NJ, Yen CF, Shim DJ, et al. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19) [published online ahead of print, 2020 May 1]. JAMA Cardiol. 2020;e201834. doi:10.1001/ jamacardio.2020.183
25. Cao B, Wang Y, Wen D, et al. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. DOI: 10.1056/ NEJMoa2001282.
26. Kai Duan et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proceedings of the National Academy of Sciences Apr 2020, 117 (17) 9490-9496; DOI: 10.1073/pnas.2004168117